Statistics for Arch Biopartners Inc (id:1259 ARCH)
Valuation metrics
Market cap
114.95M
Enterprise value
119.71M
Trailing P/E (ttm)
-35.09
Forward P/E
PEG ratio
Price/Sales (ttm)
83.08
Price/Book (mrq)
Enterprise Value/Revenue
86.52
Enterprise Value/EBITDA
-40.18
Overview
Shares outstanding
64.94M
Float
49.84M
Shares short
12.81K
% Held by insiders
3.00%
% Held by institutions
0.00%
Average volume (10 days)
17.34K
Average volume (90 days)
Price summary
52-Week low
1.36
52-Week high
2.56
52-Week change
22.04%
Beta
1.39
50-Day moving average
1.94
200-Day moving average
1.82
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
September 13, 2000
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
September 30, 2023
Most recent quarter (mrq)
March 31, 2024
Profitability
Profit margin
-185.89%
Operating margin
-138.76%
Operational effectiveness
Return on assets
-81.20%
Return on equity
60.38%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-2,572,050.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
43.95K
Total cash per share (mrq)
5.00
Total debt (mrq)
5.32M
Total Debt/Equity (mrq)
3.00
Current ratio (mrq)
20.30%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-2,716,734.00
Levered free cash flow (LFCF)
-1,504,884.00